Abstract:Abstract Abstract 3396 Poster Board III-284 OBJECTIVE: Allogeneic hematopoietic stem cell transplantation (HSCT) is a successful curative therapy for a variety of hematological malignancies. The success of allogeneic HSCT partly depends on the graft-versus-leukemia (GVL) effect caused by donor lymphocytes. Apart from alloreactive T cells, alloreactive natural killer (NK) cells also play an important role in the induction of GVL effect after HSCT. However, the effect of NK cell alloreactivity on the outcome of unrelated hematopoietic stem cell transplantation is controversial. NK cell alloreactivity after allogeneic HSCT is regulated by killer cell immunoglobulin-like receptors (KIRs). So, our study is to investigate the impact of KIRs on the outcome after unrelated hematopoietic stem cell transplantation. METHODS: 116 cases of unrelated transplants between Jan. 2001 to May. 2008 were involved in the study. The inhibitory KIRs identified with HLA ligands are as follows: KIR2DL2/KIR2DL3 bind HLA-C1; KIR2DL1 recognizes HLA-C2; and KIR3DL1 recognizes HLA-Bw4. KIR-ligand mismatch was defined as the absence of one or more recipient HLA epitopes for the corresponding donor-inhibitory KIRs. Samples containing either one or two group B haplotypes were assigned the genotype designation B/x. Samples that lacked all KIR B loci were assigned the genotype A/A. RESULTS: We found that KIR-ligand mismatch was significantly associated with a decreased leukemic relapse risk (p=0.019; HR=0.329, 95% CI 0.131-0.830), mainly in myeloid disease (p=0.003; HR=0.193, 95% CI 0.066-0.563). In myeloid disease, the cumulative risk of relapse was lower in the patients with KIR-ligand mismatch than KIR-ligand match (10.7% vs. 41.5%, p=0.002). This effect of the KIR-ligand mismatch on relapse was comparably significant between AML/MDS subgroup (12.6% vs. 40%, p=0.03) and CML subgroup (4% vs. 41.7%, p=0.008). For standard-risk myeloid leukemia, KIR-ligand mismatch resulted in a lower relapse rate than KIR-ligand match, although no statistical significance was reached. (11.3% vs. 26%, p=0.356). For high-risk myeloid leukemia, the risk of relapse in patients with KIR-ligand mismatch was significantly lower than that in patients with KIR-ligand match (9.1% vs. 71.4%, p=0.002). Furthermore, the impact of KIR-ligand mismatch was found mainly in the HLA-match group (13.9% vs. 62.5%, p= 0.001) and KIR haplotype, Bx group (11.5% vs. 55%, p=0.01). In myeloid disease, KIR-ligand mismatch also improved 5-year overall survival (OS) (p=0.034; HR=0.430, 95% CI 0.194-0.924) and disease-free survival (DFS) (p=0.024; HR=0.445, 95% CI 0.221-0.897). No effect was seen in patients with lymphoid disease. AA in the donor significantly decreased the cumulative incidence of relapse compared with Bx (12.9% vs. 28.6%, p=0.024). We further found that more activating KIR genes in the donor resulted in an increased relapse risk (p=0.005; HR=1.463, 95% CI 1.123-1.906). Meanwhile, the presence of donor activating KIR2DS3 gene was associated with increased relapse risk (p=0.003; HR=5.046, 95% CI 1.746-14.575) and decreased OS (p=0.004; HR=3.181, 95% CI 1.432–7.064) and DFS (p=0.003; HR=2.919, 95% CI 1.430-5.959) in myeloid disease. CONCLUSION: Our study indicated that, in unrelated HSCT for myeloid leukemia, selection of donors with KIR-ligand mismatch offered a lower relapse risk and a long-term survival advantage. The presence of KIR2DS3 in the donor was an important risk factor for myeloid leukemia. If donors carry low number of activating KIR genes, the risk of relapse is reduced. Disclosures: No relevant conflicts of interest to declare.

Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis

Impact of HLA High-Resolution Matching on Outcomes of Myeloablative Unrelated Donor Hematopoietic Stem Cell Transplantation in Chinese Population

[A comparison of clinical outcomes between HLA allele matched and 1 - 2 alleles mismatched unrelated allogeneic bone marrow transplantations].

Impact of HLA allele mismatch at HLA-A, -B, -C, -DRB1, and -DQB1 on outcomes in haploidentical stem cell transplantation

The effect of HLA disparity on clinical outcome after HLA-haploidentical blood and marrow transplantation.

Reduced human leukocyte antigen mismatching is associated with more favourable outcomes after unrelated donor haematopoietic stem cell transplantation

What is the impact of human leukocyte antigen mismatching on graft survival and mortality in renal transplantation? A meta-analysis of 23 cohort studies involving 486,608 recipients

The Impact of HLA-A,HLA-B,HLA-DRB1 High-Resolution Matching on the Prognosis of Hematopoietic Stem Cell Transplantation from Unrelated Donors:A Retrospective Report

HLA‐DPB1 and DPA1 ~ DPB1 linkage mismatch affects the survival of recipients receiving HLA‐14/14 matched unrelated donor HSCT

Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation

Machine Learning Insights into HLA Noncoding Sequence Mismatches and Their Impact on DPB1 Matching in Hematopoietic Cell Transplantation

Impact of donor characteristics and HLA matching on survival of chinese patients with hematologic malignancies undergoing unrelated hematopoietic stem cell transplantation.

Effect of human leukocyte antigen mismatching on the outcomes of pediatric kidney transplantation: a systematic review and meta-analysis.

Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies

Class II HLA mismatch improves outcomes following haploidentical transplantation with posttransplant cyclophosphamide

[The Impact of HLA Matching on Outcome of Single Unit Unrelated Cord Blood Transplantation: a Retrospective Single Center Clinical Analysis].

The Beneficial Impact of Kir-Ligand Mismatch and Absence of Donor-Kir2ds3 Gene on Outcome Following Unrelated Donor Stem Cell Transplantation for Myeloid Leukemia

Effect of Multiple HLA Locus Mismatches on Outcomes after Single Cord Blood Transplantation

HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide

The Impact of Human Leukocyte Antigen Mismatching on Graft Survival and Mortality in Adult Renal Transplantation: A Protocol for a Systematic Review and Meta-Analysis.

Impact of HLA Molecular Mismatch on Haploidentical Hematopoietic Stem Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study